U.S. flag

An official website of the United States government

NM_000545.8(HNF1A):c.130del (p.Leu44fs) AND Maturity-onset diabetes of the young type 3

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 18, 2011
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000030478.3

Allele description [Variation Report for NM_000545.8(HNF1A):c.130del (p.Leu44fs)]

NM_000545.8(HNF1A):c.130del (p.Leu44fs)

Gene:
HNF1A:HNF1 homeobox A [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q24.31
Genomic location:
Preferred name:
NM_000545.8(HNF1A):c.130del (p.Leu44fs)
Other names:
NM_000545.8(HNF1A):c.130del; p.Leu44fs
HGVS:
  • NC_000012.12:g.120978898del
  • NG_011731.2:g.5153del
  • NM_000545.8:c.130delMANE SELECT
  • NM_001306179.2:c.130del
  • NP_000536.6:p.Leu44fs
  • NP_001293108.2:p.Leu44fs
  • LRG_522t1:c.130del
  • LRG_522:g.5153del
  • NC_000012.11:g.121416701del
  • NM_000545.5:c.130delC
  • p.Leu44TrpfsX111
Protein change:
L44fs
Links:
dbSNP: rs193922578
NCBI 1000 Genomes Browser:
rs193922578
Molecular consequence:
  • NM_000545.8:c.130del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001306179.2:c.130del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Maturity-onset diabetes of the young type 3
Synonyms:
Diabetes mellitus MODY type 3; MODY hepatocyte nuclear factor-1-alpha related; MODY type 3; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010894; MedGen: C1838100; Orphanet: 552; OMIM: 600496

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000053148Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
pathogenic
(Aug 18, 2011)
germlinecuration, clinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes7not providednot provided7not providedcuration
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Citations

PubMed

Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect.

Klupa T, Warram JH, Antonellis A, Pezzolesi M, Nam M, Malecki MT, Doria A, Rich SS, Krolewski AS.

Diabetes Care. 2002 Dec;25(12):2292-301.

PubMed [citation]
PMID:
12453976

Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).

McKinney JL, Cao H, Robinson JF, Metzger DL, Cummings E, Riddell DC, Sanderson SR, Pacaud D, Ho J, Hegele RA.

Clin Invest Med. 2004 Jun;27(3):135-41.

PubMed [citation]
PMID:
15305805

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000053148.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedcuration PubMed (2)
2not provided3not providednot providedcuration PubMed (2)
3not providednot providednot providednot providedclinical testing PubMed (2)

Description

"Author mentions variant detected in 4 members from a Caucasian family diagnosed with diabetes; the average age at onset was 11 with a range from 10-13; Controls not tested"
"Variant found in 3 members of a Canadian family, 24 yr old mother, 18 yr old son and 14 yr old daughter, Mother and daughter's treatment include diet while insulin being the treatment method for son; Not found in normoglycemic Controls see PbGP."

Description

Converted during submission to Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes4not providednot provided4not providednot providednot provided
2germlineyes3not providednot provided3not providednot providednot provided
3germlineunknownnot providedBloodassert pathogenicitynot providednot providednot provided See 3

Co-occurrences

#ZygosityAllelesNumber of Observations
3SingleHeterozygoteTCF1:c.1720A>G1

Last Updated: May 1, 2024